Renal Denervation in End Stage Renal Disease Patients With Refractory Hypertension

Completed · Phase 1

Conditions studied: Kidney Failure, Chronic, Renal Dialysis

In brief

The purpose of this this study is to investigate the clinical utility of renal denervation in the treatment of ESRD patients with refractory hypertension.

Key facts

Study ID

NCT00753116

Run by

Medtronic Vascular

People needed

20

Starts

2008-09-01

Expected to finish

2009-12-01

Last updated by the study team

2012-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Systolic blood pressure of 160 mmHg or greater
• On 3 or more antihypertensive medications
• On dialysis for more than 6 months

You may not qualify if…

• Renal artery abnormalities
• Known secondary hypertension attributable to a cause other than sleep apnea
• MI, angina, CVA within 6 months
• Others

Where it is running

• Hennepin County Medical Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.